Abstract
References
1.
Alarcon-Segovia
D
. (1969 ) Mayo Clinic Proceedings
44 , 664 .
2.
Amos
H E
Brigden
W D
McKerron
R A
. (1975 ) British Medical Journal
i , 598 .
3.
Bendtzen
K
Soborg
M
. (1975 ) Lancet
i , 629 .
4.
Brown
P
Baddeley
H
Read
A E
Davies
J P
McGarry
J
. (1974 ) Lancet
ii , 1477 .
5.Committee on Safety of Medicines (1975 ) Adverse Reactions Series No. 11.
6.
Dunlop
D
Shanks
R G
. (1968 ) British Journal of Pharmacology
32 , 201 .
7.
Fan
Y S
Condon
Y R
Brooks
P L
Rhodes
J
Dexter
H
Robinson
V
. (1975 ) Lancet
i , 630 .
8.
Felix
R H
Ire
F A
Dahl
M G C
. (1974 ) British Medical Journal
iv , 321 .
9.
(1975 ) British Medical Journal
i , 626 .
10.
Hughes
G R
. (1971 ) Lancet
ii , 861 .
11.
Raftery
E B
Denman
A M
. (1973 ) British Medical Journal
ii , 452 .
12.
Wright
P
. (1975 ) British Medical Journal
i , 595 .